Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 11235 filtered startups

Updropp

Updropp wants to transform electronic waste into resources. We do this by enabling citizens to get rid of their electronic devices, especially household equipment, in an easy and responsible manner, so they can be sent back into the flow. This is done through our "Uptainers", conveniently placed outdoor drop-off stations. At the Uptainers, citizens are able to place electronics, they no longer use, while running their daily errands. Other citizens can then use the Uptainer to find "new" electronics they can take home and give new life. To support the Uptainers, we are developing an application, that shows an overview of Uptainers and the items placed in them and gives the users statistics showing their personal impact as well as the combined impact. Updropp is a one-person startup, being developed with ongoing help from advisors, collaborators, and interns. We are still in the discovery/product development phase. Right now we have a BETA version of our Uptainer placed at Det Bæredygtige Forsamlingshus, and are using this to gather insight for our 1.0 design of the Uptainer. We expect that to be ready for launch in primo 2024.

Invenio Growth Consulting

As a passionate and experienced team of entrepreneurs, strategy consultants and VC specialists, Invenio Growth navigates the digital transformation to guide organisations from venture strategy advisory to operational venture building. In the epicenter of VC funds, global corporates and the start-up scene, Invenio Growth drives digital growth strategy and open innovation by leveraging data-driven AI and industry leading technology, empowering our partners to thrive in the digital age. Together with our partners we transform digital innovation into sustainable value for the future.

GlossGods

We are a female based company from the northern part of Sweden that calls ourselves GODS. Not Goddesses. We don’t think that the word should be for just the male pronoun/gender. We think that makeup and beauty is Genderfluid. We wanted to create a brand that gives everyone the chance to take charge of their own creativity and self expression, unapologetically of who you are, when the occasion is or how much make up you would like to wear and even if you don’t want to wear no make up at all. You should be your own GOD and have the power to make your own decisions and not what the society thinks you should.

schhh

We are the first agency in the Nordics fully specialised in Customer Experience. We can help you accelerate the implementation of scalable processes and technologies. We focus on shaping the best Customer Journey, leveraging every touch-point. We have worked with Climate, Health, Security, Marketplace, E-commerce, EdTech, Fashion ERP, and SaaS, solving diverse challenges in Customer Support and Customer Success. We work towards digital customer-centricity with every team, enabling churn prevention and continuous optimisation. In our experience, there is no out-of-the box customer journey plan or a silver bullet that will make it all work. We work on shaping the touch-points that will make the formula succeed, unique to every company. We work with small and medium businesses with online distribution, B2B and B2B2C.

Global Shapers Oslo

The Oslo Hub is made up of exceptionally talented and diverse young Norwegians committed to shaping our community and laying the groundwork for a better society - locally and globally. Our Hub consists of Shapers from all walks of life, professions, backgrounds, genders, ethnicities, and fields, including entrepreneurs, creative industry people, artists and dancers, corporate professionals, refugees, and athletes. While we have a unified mission for our Hub, we benefit from the diversity in our backgrounds to solve common problems to create a better society and world. Our motto is; "Think big. Start young. Shape the world!"

Nordiq Products AS

The founder, Mats Hetling, experienced losing a patient due to a lack of control of a patient's vital signs in a mass casualty accident. This felt unnecessary, so we started Nordiq Products to solve the problem. Our solution to the problem is a lightweight and user-friendly device with several different sensors to make it robust and reliable in any operational environment.

Helly Hansen

Helly Hansen is a leader in technical sailing and performance ski apparel, as well as premium workwear. Founded in Norway in 1877, Helly Hansen strives to develop professional-grade gear that helps people stay and feel alive. Trusted by over 60,000 professionals worldwide, the company has developed a long list of first-to-market innovations, including the first supple waterproof fabrics over 140 years ago. Other breakthroughs include the first fleece fabrics, the first technical base layers made with Lifa® Technology, and the award-winning and patented H2Flow™ temperature regulating system and Lifaloft™ insulation by Primaloft®.

OKTO

OKTO is a gamification of outdoor cycling. OKTO gives you the fun of friendly competition, you compete with riders on your own level - both locally and all over the world. By completing quests, journeys, and achievements you gain OKTO points, fun rewards, titles, and more to help you reach the next level.

Homely AS

Homely leverer boligalarm tilknyttet døgnåpen, FG-godkjent alarmstasjon. Med en fast lav månedspris og en moderne og fleksibel smarthus-plattform er Homely en boligalarm for folk flest. Alle sikkerhetsprodukter styres fra Homely-appen. Homely har inngått avtale med Storebrand forsikring som tilbyr og anbefaler løsningen til sine kunder.

SonoClear AS

SonoClear AS develops an acoustic contrast fluid to remove noise in ultrasound images, used during brain tumor surgery to guide tumor removal. The goal is to be sure that all tumor is removed, as total resection improves patient outcomes. The technology is developed by neurosurgeons at St.Olavs hospital and engineers at Sintef. The technology is patented worldwide and is developed as a medical device according to ISO13485. The core team consists of CTO, Medical advisor, Quality manager, and Regulatory officer. SonoClear plan for market access in USA and EU in 4q20 and 4q21, respectively.

Gameflow AS

We believe that live esports should be available to everyone, in a way that makes it easy to follow and easy to understand. Our goal is to make it available anytime, anywhere, and to unify it all in one place. That’s why we’re building a platform that will revolutionize the way you consume live esports.

Elife AS

Elife E-bikesWe design and import components directly from industries (Germany etc.) and handmake e-bikes in Norway. This is the 3 rd year for us, we have our shop in Oslo and started our focus on developing&producing. We have distributors in Norway and Iceland. Our advantage is that all our competitors can be potential partners. In 2018, we have handmade the lightest three-seater "e-bike-car" in the world - iCloud. It allows 2 People to pedal at the same time. It protects you from bad weather & has a 150L trunk. Its battery range is 200km.

HTTECH

HTTECH's mission is to support heavy industries on the way to sustainable development. HTTECH's vision: Contribute to solving environmental challenges for the established industry in a cost-efficient manner and produce nano-based materials for the future to transform waste into high-value products with high-demand. Build sustainable business in the space of circular economyHTTECH is a company with a solid competence in the field of high-temperature technologiesExpertise: R&D projects in the fields of Hydrogen and Solar Energetics, Energy Savings, Oil&Gas Industry, Computer ModelingMetallurgy & Chemical Engineering, Materials Science and International Business Development Industrial expertise

CardiNor AS

CardiNor AS er et norsk bioteknologiselskap etablert for å håndtere kommersialiseringen av secretoneurin, en ny biomarkør test for hjertekar sykdom. Vår innovasjon er en ny og proprietær hjertekar test – secretoneurin. Secretoneurin er vist å ha sterk prognostisk nytteverdi hos pasienter med hjertesvikt, og den har et særskilt stort potensial hos pasienter med hjerterytmeforstyrrelser (arytmi). Hjertekar sykdom er fortsatt den viktigste dødsårsaken i verden i dag. Ingen av de kjent og etablerte biomarkørene for hjertekar sykdom er til særlig hjelp i valg av medisinske, og eller kirurgiske behandlingsmetoder for å forhindre livstruende hjerterytmeforstyrrelser. Selskapet utvikler nå en brukervennlig forskningstest for å måle secretoneurin blod som vil markedsført og solgt gjennom et nettverk av distributører i Europa og USA. Dette etterfulgt av introduksjonen av et CE-merket produkt for klinisk bruk i Europa og regulatorisk godkjenning i USA. CardiNor-ledelsen har inngående kunnskap om og erfaring fra bioteknologi og diagnostisk industri som dekker hele livssyklus fra oppstart til exit. CardiNor samarbeider med verdensledende akademiske institusjoner og opinionsledere og industri i å utvikle og dokumentere biomarkør testen.

Biozep AS

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.